-transparent.png){kind=logo}
A patient with epilepsy controlled by carbamazepine developed a carbamazepine neurotoxic reaction after being given an increased dosage of diltiazem hydrochloride as adjunctive therapy. Abrupt withdrawal of diltiazem reduced the circulating carbamazepine concentration and resulted in an epileptic attack. Awareness of the interaction between diltiazem and carbamazepine and careful monitoring of carbamazepine blood levels is recommended to prevent the dangerous neurotoxic effect associated with this combination.
Related Publications
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
November 1988,
Cancer,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
December 1990,
American heart journal,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
January 1980,
The Medical journal of Australia,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
May 1986,
British medical journal (Clinical research ed.),
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
June 2005,
International journal of pharmaceutics,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
January 1983,
European journal of clinical pharmacology,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
April 1992,
Neurology,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
April 1987,
Drug intelligence & clinical pharmacy,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
July 2015,
Epilepsia,
E Maoz, and
E Grossman, and
M Thaler, and
T Rosenthal
May 1953,
Deutsche medizinische Wochenschrift (1946),
